Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis

Chinese Medical Journal

Volumn 116, Issue 4, 2003, Pages 549-553

  Xie, Honglang ^a   Ji, Daxi ^a   Gong, Dehua ^a   Liu, Yun ^a   Xu, Bin ^a   Zhou, Hong ^a   Liu, Zhihong ^a   Li, Leishi ^a   Li, Weiqin ^b   Quan, Zhufu ^b   Li, Jieshou ^b  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute necrotizing pancreatitis; Multiple organ dysfunction syndrome; Veno venous hemofilration

Indexed keywords

ANTICOAGULANT AGENT; INTERLEUKIN 1; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; PHOSPHATE; PROSTAGLANDIN E; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ACUTE HEART FAILURE; ACUTE HEMORRHAGIC PANCREATITIS; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ARTICLE; BLEEDING TENDENCY; BLOOD FLOW VELOCITY; BRAIN DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOFILTRATION; HUMAN; HYPOPHOSPHATEMIA; INTENSIVE CARE UNIT; LUNG EDEMA; MALE; MORTALITY; MYCOSIS; PERITONEAL CAVITY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SHOCK; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; ULTRAFILTRATION;

ADULT; AGED; FEMALE; HEMOFILTRATION; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037944098     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mao EQ, Tang YQ, Han YQ, et al. Effects of short venovenous hemofiltration on the severe acute pancreatitis. Chin J Surg 1999;37:142-143.
2. Banks PA. Practice guideline in acute pancreatitis. Am J Gastroenterol 1997;92:377-386.
3. Balthazar EJ, Ranson JHC, Naidich DP, et al. Acute pancreatitis: prognostic value of CT. Radiology 1985;156: 767-772.
4. Bone RC, Balk RA, Cerra FB, et al. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655.
5. Ji DX, Xie HL, Liu Y, et al. The application of continuous renal replacement therapy in the treatment of severe acute renal failure. J Nephrol Dialy Transplant 1997;6:415-421.
6. Yekebas EF, Treede H, Knoefel WT, et al. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999;229:514-522.
7. Norman JG, Franz MG, Fink GS, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995;221:625-634.
8. Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNF-alpha therapy improves survival and ameliorates the pathophysiologic sequelae in acure pancreatits in the rat. Am J Surg 1996;171:274-280.
9. Hughes CB, Gaber LW, Mohey el Din AB, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 1996;62:8-13.
10. Bellomo R, Baldwin I, Cloe L, et al. Preliminary experience with high-volume hemofilatration in human septic shock. Kidney Int 1998;53(S66):182-185.
11. Beger HG, Rau B, Mayer J, et al. Natural course of acute pancreatitis. World J Surg 1997;21:130-135.
12. Yao ZX. Understanding modern treatment of severe pancreatitis. Chin J Hepatobiliary Sur 1999;5:76-78.